Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
27853915
DOI
10.1007/s11255-016-1460-3
PII: 10.1007/s11255-016-1460-3
Knihovny.cz E-zdroje
- Klíčová slova
- Apparent diffusion coefficient, Diffusion-weighted imaging, Magnetic resonance imaging, Renal cell carcinoma,
- MeSH
- diferenciální diagnóza MeSH
- difuzní magnetická rezonance metody MeSH
- dospělí MeSH
- karcinom z renálních buněk * diagnóza patologie MeSH
- ledviny * diagnostické zobrazování patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- přesnost dimenzionálního měření MeSH
- prognóza MeSH
- reprodukovatelnost výsledků MeSH
- senioři MeSH
- staging nádorů MeSH
- stupeň nádoru MeSH
- výběr pacientů MeSH
- zlepšení kvality MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Renal cell carcinoma (RCC) represents the most common malignant epithelial neoplasm of the kidney. Accurate assessment of the renal masses, defining the histologic subtype and the grade of differentiation of the tumor, is vital to ensure an adequate case management as well as for staging and prognosis. Recently, diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) tends to be increasingly appealing for the clinicians as an imaging procedure of choice for the diagnosis and staging of the RCC, which is predetermined by several advantages over CT. The goal of the survey was to assess the applicability of the apparent diffusion coefficient (ADC) of the DWI MRI for the differential diagnostics, histologic subtyping, and defining the grade of differentiation of the RCC. METHODS: The study enrolled 288 adult patients with renal lesions: 188 patients with solid RCC-126 patients with clear cell subtype (ccRCC), 32 patients with papillary RCC (pRCC), 30 patients with chromophobe RCC (chRCC); 27 patient with cystic form or RCC (Bosniak cyst, category IV); 32 patients with renal angiomyolipoma (AML); 25 patients with renal oncocytoma (OC); and 16 patients with the renal abscess (AB). In total, 245 lesions were pathologically verified. As a reference, 19 healthy volunteers were included into the study. All patients underwent MRI of the kidneys, involving DWI with subsequent evaluation of the ADC. RESULTS: There was a reliable difference (p < 0.05) in mean ADC values between the normal renal parenchyma (NRP), solid RCC of different histologic subtypes and grades, cystic RCC, and benign renal lesions. The mean ADC values obtained in the result of the study were (×10-3 mm2/s): 2.47 ± 0.12 in NRP, 1.63 ± 0.29 in all solid RCCs, 1.82 ± 0.22 in solid ccRCC (1.92 ± 0.11-Fuhrman grade I, 1.84 ± 0.14-Fuhrman grade II, 1.79 ± 0.10-Fuhrman grade III, 1.72 ± 0.06-Fuhrman grade IV), 1.61 ± 0.07 in pRCC, 1.46 ± 0.09 in chRCC, 2.68 ± 0.11 in cystic RCC, 2.13 ± 0.08 in AML, 2.26 ± 0.06 in OC, and 3.30 ± 0.07 in AB. CONCLUSION: The data received in our study demonstrate a substantial restriction of diffusion of hydrogen molecules in tissues of ccRCC in comparison with the healthy renal parenchyma preconditioned by the greater density of tumor. A statistically significant difference in mean ADC values of ccRCC with different grades of nuclear pleomorphism by Fuhrman was observed: Low-grade tumors showed higher mean ADC values compared to high-grade tumors. The modality of the MRI DWI along with ADC measurement allows to reliably differentiate between the solid RCC of main histologic subtypes and grades, cystic RCC, and the benign renal lesions.
2nd Department of Surgery Faculty of Medicine Masaryk University Brno Czech Republic
Department of Radiology Lviv National Medical University Lviv Ukraine
Department of Urology Lviv National Medical University Pekarska str 69 Lviv Ukraine
Euroclinic Medical Center Lviv Ukraine
University of Oviedo Central University Hospital of Asturias Oviedo Spain
Zobrazit více v PubMed
BJU Int. 2011 Feb;107(3):409-15 PubMed
J Urol. 2006 Feb;175(2):459-62 PubMed
Magn Reson Imaging. 2016 Dec;34(10 ):1341-1345 PubMed
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49 PubMed
Radiology. 2010 Oct;257(1):135-43 PubMed
Pol J Radiol. 2014 Sep 01;79:290-5 PubMed
Am J Surg Pathol. 2003 May;27(5):612-24 PubMed
Radiology. 2016 Jan;278(1):306 PubMed
J Urol. 2005 Aug;174(2):451-5; discussion 455 PubMed
Eur Urol. 2009 Nov;56(5):775-81 PubMed
AJR Am J Roentgenol. 2010 Nov;195(5):W344-51 PubMed
J Comput Assist Tomogr. 2011 May-Jun;35(3):332-6 PubMed
AJR Am J Roentgenol. 2010 Feb;194(2):438-45 PubMed
Radiographics. 2008 Jul-Aug;28(4):985-1003 PubMed
Magn Reson Q. 1991 Jan;7(1):1-30 PubMed
AJR Am J Roentgenol. 2002 Jun;178(6):1499-506 PubMed
Abdom Radiol (NY). 2016 Oct;41(10 ):1997-2010 PubMed
Radiology. 2009 May;251(2):398-407 PubMed
Eur Radiol. 2014 Jan;24(1):241-9 PubMed